Single-cell RNA sequencing in cancer: Applications, advances, and emerging challenges

• Published in: Molecular therapy. Oncolytics 2021-06, Vol.21, p.183-206
• Main Authors: Sun, Guangshun, Li, Zhouxiao, Rong, Dawei, Zhang, Hao, Shi, Xuesong, Yang, Weijun, Zheng, Wubin, Sun, Guoqiang, Wu, Fan, Cao, Hongyong, Tang, Weiwei, Sun, Yangbai
• Format: Article
• Language: English
• Subjects: carcinoma; carcinoma stem cells; Review; single-cell RNA sequencing; tumor microenvironment; tumor resistance
• ISSN: 2372-7705; 2372-7705
• DOI: 10.1016/j.omto.2021.04.001

Cancer has become one of the greatest threats to human health, and new technologies are urgently needed to further clarify the mechanisms of cancer so that better detection and treatment strategies can be developed. At present, extensive genomic analysis and testing of clinical specimens shape the insights into carcinoma. Nevertheless, carcinoma of humans is a complex ecosystem of cells, including carcinoma cells and immunity-related and stroma-related subsets, with accurate characteristics obscured by extensive genome-related approaches. A growing body of research shows that sequencing of single-cell RNA (scRNA-seq) is emerging to be an effective way for dissecting human tumor tissue at single-cell resolution, presenting one prominent way for explaining carcinoma biology. This review summarizes the research progress of scRNA-seq in the field of tumors, focusing on the application of scRNA-seq in tumor circulating cells, tumor stem cells, tumor drug resistance, the tumor microenvironment, and so on, which provides a new perspective for tumor research. [Display omitted] Sequencing of single-cell RNA (scRNA-seq) is emerging to be an effective way for dissecting human tumor tissue at single-cell resolution, presenting one prominent way for explaining carcinoma biology. This review summarizes the research progress of scRNA-seq in the field of tumors, which provides a new perspective for tumor research.